Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer.

Fernández-Luna C, Baena J, Calles A, Antoñanzas-Basa M, Lage Alfranca Y, Mielgo X, Sereno M, Cervera R, Cabezon-Gutierrez L, López A, Rubio J, Conde E, Lopez-Rios F, Alvarez-Vallina L, Valencia K, Montuenga LM, Ruiz De Garibay G, Molero M, Adradas V, Curto-Aguilera D, Peressini M, Carrera-Elvira E, Ballesteros D, Portillo-Fernández A, Lopez-Cárdenas T, Serrano-Gómez C, Bote H, Torres-Jiménez J, Cruz-Bermúdez A, Provencio M, Paz-Ares L, Sánchez-Herrero E, Zugazagoitia J.

Open source

DOI: 10.1136/jitc-2026-016133
Published: 2026-09-12
Container: J Immunother Cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-016133,
  title = {Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer.},
  author = {Fernández-Luna C and  Baena J and  Calles A and  Antoñanzas-Basa M and  Lage Alfranca Y and  Mielgo X and  Sereno M and  Cervera R and  Cabezon-Gutierrez L and  López A and  Rubio J and  Conde E and  Lopez-Rios F and  Alvarez-Vallina L and  Valencia K and  Montuenga LM and  Ruiz De Garibay G and  Molero M and  Adradas V and  Curto-Aguilera D and  Peressini M and  Carrera-Elvira E and  Ballesteros D and  Portillo-Fernández A and  Lopez-Cárdenas T and  Serrano-Gómez C and  Bote H and  Torres-Jiménez J and  Cruz-Bermúdez A and  Provencio M and  Paz-Ares L and  Sánchez-Herrero E and  Zugazagoitia J.},
  year = {2026},
  journal = {J Immunother Cancer},
  doi = {10.1136/jitc-2026-016133},
  url = {https://doi.org/10.1136/jitc-2026-016133}
}

RIS

TY  - JOUR
TI  - Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer.
AU  - Fernández-Luna C
AU  -  Baena J
AU  -  Calles A
AU  -  Antoñanzas-Basa M
AU  -  Lage Alfranca Y
AU  -  Mielgo X
AU  -  Sereno M
AU  -  Cervera R
AU  -  Cabezon-Gutierrez L
AU  -  López A
AU  -  Rubio J
AU  -  Conde E
AU  -  Lopez-Rios F
AU  -  Alvarez-Vallina L
AU  -  Valencia K
AU  -  Montuenga LM
AU  -  Ruiz De Garibay G
AU  -  Molero M
AU  -  Adradas V
AU  -  Curto-Aguilera D
AU  -  Peressini M
AU  -  Carrera-Elvira E
AU  -  Ballesteros D
AU  -  Portillo-Fernández A
AU  -  Lopez-Cárdenas T
AU  -  Serrano-Gómez C
AU  -  Bote H
AU  -  Torres-Jiménez J
AU  -  Cruz-Bermúdez A
AU  -  Provencio M
AU  -  Paz-Ares L
AU  -  Sánchez-Herrero E
AU  -  Zugazagoitia J.
PY  - 2026
JO  - J Immunother Cancer
DO  - 10.1136/jitc-2026-016133
UR  - https://doi.org/10.1136/jitc-2026-016133
ER  -

APA

C, F., J, B., A, C., M, A., Y, L. A., X, M., M, S., R, C., L, C., A, L., J, R., E, C., F, L., L, A., K, V., LM, M., G, R. D. G., M, M., V, A., D, C., M, P., E, C., D, B., A, P., T, L., C, S., H, B., J, T., A, C., M, P., L, P., E, S., & J., Z. (2026). Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer.. J Immunother Cancer. https://doi.org/10.1136/jitc-2026-016133

Source records

europe-pmc · retrieved 2026-09-25T07:47:49.792Z
doaj · retrieved 2026-09-25T07:47:49.800Z